These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 232690)

  • 1. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.
    Murthy KK; Calnek BW
    Infect Immun; 1979 Nov; 26(2):547-53. PubMed ID: 232690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease.
    Powell PC; Rowell JG
    J Natl Cancer Inst; 1977 Sep; 59(3):919-24. PubMed ID: 197249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody directed against Marek's disease-associated tumor surface antigen can be eluted from Marek's disease tumor cells.
    Pradhan HK; Mohanty GC; Lee WY; Patnaik B
    Vet Immunol Immunopathol; 1991 Sep; 29(3-4):229-38. PubMed ID: 1659032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1977 Jun; 58(6):1647-51. PubMed ID: 68120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of chickens against Marek's disease with cell-free supernatant from the JMV-1 lymphoblastoid cell line.
    Keller LH; Belden KA; Sevoian M
    Prog Clin Biol Res; 1987; 238():265-79. PubMed ID: 3037562
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.
    Lesnik F; Ross LJ
    Int J Cancer; 1975 Jul; 16(1):153-63. PubMed ID: 170213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marek's disease in chickens: development of viral antigen in feather follicles and of circulating antibodies.
    Steck F; Haberstich HU
    Infect Immun; 1976 Apr; 13(4):1037-45. PubMed ID: 179946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
    Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
    Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marek's disease vaccines.
    Calnek BW
    Dev Biol Stand; 1982; 52():401-5. PubMed ID: 6299850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antigen associated with the Marek's disease lymphoblastoid cell line MSB-1.
    Ross LJ
    J Gen Virol; 1982 Jun; 60(Pt 2):375-80. PubMed ID: 6286857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
    Nazerian K; Lee LF; Yanagida N; Ogawa R
    J Virol; 1992 Mar; 66(3):1409-13. PubMed ID: 1310755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of virus-specific, thymus-specific and tumour-specific antigens in lymphoblastoid cell lines derived from Marek's disease lymphomas.
    Ross LJ; Powell PC; Walker DJ; Rennie M; Payne LN
    J Gen Virol; 1977 May; 35(2):219-35. PubMed ID: 69011
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection.
    Calnek BW; Schat KA; Ross LJ; Shek WR; Chen CL
    Int J Cancer; 1984 Mar; 33(3):389-98. PubMed ID: 6321364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marek's disease tumor-associated surface antigen (MATSA) in resistant versus susceptible chickens.
    Murthy KK; Calnek BW
    Avian Dis; 1979; 23(4):831-7. PubMed ID: 232656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of culture temperature on the production of Marek's disease virus antigens in a chicken lymphoblastoid cell line.
    Arita K; Nii S
    Biken J; 1979 Mar; 22(1):31-4. PubMed ID: 231431
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to Marek's disease: where are we now?
    Haq K; Schat KA; Sharif S
    Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.